HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition.

He YX, Song XH, Zhao ZY, Zhao H.

Open source

DOI
10.26355/eurrev_202205_28830
Published
2022-05-01
Container
Eur Rev Med Pharmacol Sci
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_202205_28830,
  title = {HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition.},
  author = {He YX and  Song XH and  Zhao ZY and  Zhao H.},
  year = {2022},
  journal = {Eur Rev Med Pharmacol Sci},
  doi = {10.26355/eurrev_202205_28830},
  url = {https://doi.org/10.26355/eurrev_202205_28830}
}

RIS

TY  - JOUR
TI  - HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition.
AU  - He YX
AU  -  Song XH
AU  -  Zhao ZY
AU  -  Zhao H.
PY  - 2022
JO  - Eur Rev Med Pharmacol Sci
DO  - 10.26355/eurrev_202205_28830
UR  - https://doi.org/10.26355/eurrev_202205_28830
ER  - 

APA

YX, H., XH, S., ZY, Z., & H., Z. (2022). HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition.. Eur Rev Med Pharmacol Sci. https://doi.org/10.26355/eurrev_202205_28830

Source records